Hosted on MSN12h
Astros Get Under the Tax, Trade Ryan Pressly to the Cubs
The Chicago Cubs have acquired reliever Ryan Pressly from the Houston Astros in exchange for 20-year-old pitching prospect ...
Eli Lilly: Big 2025 Ahead, But Execution Risks Exist
Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...
ESPN4d
Former D-backs reliever Sewald joins Guardians on one-year deal
He's the third reliever to leave the AL Central champions this winter, following Eli Morgan and Nick Sandlin, who were both traded.
Yahoo Finance4d
Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on ...
The Washington Post4d
Reliever Paul Sewald and Guardians agree to $7 million, 1-year contract
He’s the third reliever to leave the AL Central champions this winter, following Eli Morgan and Nick Sandlin, who were both traded.
Eli Lilly and Company (LLY) CEO Dave Ricks presents at 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
Eli Lilly and Company (NYSE:LLY) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 5:15 PM ETCompany ParticipantsDave Ricks - Chairman ...
Business Insider12d
Eli Lilly Q4 miss brings buying opportunity, says JPMorgan
JPMorgan analyst Chris Schott says Eli Lilly’s (LLY) Q4 miss represents a buying opportunity as the company is positioned for strong growth in 2025. The company’s 2025 sales guidance ...